New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2013
19:00 EDTAHLAspen Insurance announces $150M accelerated share repurchase program
Aspen Insurance Holdings Limited announced that it has entered into an Accelerated Share Repurchase, or ASR, agreement with Goldman, Sachs & Co. to repurchase an aggregate of $150M of Aspen's ordinary shares under an accelerated share repurchase program. From January 1 through February 26, Aspen also repurchased approximately $47M of its ordinary shares in the open market. Under the ASR agreement, Aspen will pay $150M to Goldman in exchange for Aspen's ordinary shares. Aspen expects the substantial majority of shares to be delivered on March 1. Based on Aspen's closing share price on February 26, the ASR program and the completed open market share repurchases from January 1, together represent approximately 8% of the company's current total market capitalization. Aspen will have approximately $335M remaining under its current $500M share repurchase program authorized by the board and announced on February 7. The ordinary shares will be retired once repurchased.
News For AHL From The Last 14 Days
Check below for free stories on AHL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
16:31 EDTAHLAspen Insurance expects operating ROE of 10% in 2014
Subscribe for More Information
16:30 EDTAHLAspen Insurance raises quarterly dividend to 20c from 18c per share
Subscribe for More Information
16:28 EDTAHLAspen Insurance reports Q1 EPS $1.66, consensus $1.07
April 17, 2014
12:54 EDTAHLEndurance Specialty CFO comments on Aspen's poison pill adoption
Endurance Specialty Holdings (ENH) commented on Aspen Insurance's (AHL) adoption of a poison pill "shareholder rights plan" in response to Endurance's April 14 proposal to acquire all of the common shares of Aspen for $3.2B, or $47.50 per Aspen share, with a combination of cash and Endurance common shares. Michael J. McGuire, CFO of Endurance, said: "At a time when the Aspen board should be seriously considering an opportunity to deliver significant value to its shareholders, it is instead focused on blocking them from receiving that value and on taking actions to entrench themselves. This is not a surprise given the lack of alignment and clear disdain Aspen's Board has shown for its shareholders in summarily rejecting our proposal without any discussion whatsoever. A poison pill is a well documented defensive step typically taken by an entrenched board of directors. It's interesting Aspen's Board adopted a poison pill that divides their shareholders into different categories - good and bad, passive and active - a division that is currently the subject of litigation in an unrelated situation. As if it weren't clear before, Aspen shareholders now have further evidence of their Board's deliberate actions to prevent them from receiving attractive value for a strategically sound acquisition. We remain fully committed to delivering our highly attractive premium offer to Aspen shareholders," McGuire concluded.
09:13 EDTAHLAspen Insurance adopts one-year shareholder rights plan
Subscribe for More Information
April 14, 2014
16:11 EDTAHLBarclays upgrades Aspen Insurance, sees start of reinsurance consolidation cycle
Subscribe for More Information
15:48 EDTAHLAspen Insurance upgraded to Equalweight from Underweight at Barclays
14:20 EDTAHLEndurance Chairman says willing to invest $25M of own funds in Aspen transaction
Subscribe for More Information
14:18 EDTAHLEndurance Specialty expects Aspen holders to recognize value of proposed deal
Subscribe for More Information
12:26 EDTAHLOn The Fly: Midday Wrap
Subscribe for More Information
12:00 EDTAHLAspen Insurance rises 11.3%
Subscribe for More Information
10:41 EDTAHLAspen rejects offer from Endurance, sees no purpose in meeting
Subscribe for More Information
10:24 EDTAHLAspen Insurance jumps after receiving buyout proposal
Shares of Aspen Insurance (AHL) are rising after a peer in the insurance and reinsurance industry, Endurance Specialty (ENH), offered to buy the company. WHAT'S NEW: Endurance Specialty announced that it had sent a takeover proposal to Aspen, offering to buy the company for $3.2B, or $47.50 per share. Endurance offered Aspen shareholders the right to receive, at their election, all cash, all Endurance common shares, or a combination of cash and Endurance common shares in exchange for their stake in Aspen. Endurance, which said the cash consideration to be offered will be funded from cash resources and $1.05B of newly issued common shares to investors, argues that the combined company would be a global leader in specialty insurance and reinsurance with increased scale, market presence, diversification and profit potential and over $5 billion of combined annual gross premiums written. PRICE ACTION: In early trading, Aspen climbed $6.01, or 15.27%, to $45.38 and Endurance Specialty fell 2.95% to $52.23 before shares of both companies were halted for trading around 10 am ET. Other reinsurers rose, with Montpelier Re (MRH) advancing 2.2% to $29.94, Platinum Underwriters (PTP) gaining 1% to $60, and Validus (VR) adding 0.8% to $37.59.
10:07 EDTAHLAspen Insurance trading halted, pending news
Subscribe for More Information
10:00 EDTAHLAspen Insurance rises 15.1%
Subscribe for More Information
09:00 EDTAHLAspen Insurance rises 21.4%
Subscribe for More Information
08:38 EDTAHLEndurance Specialty offers to buy Aspen Insurance for $3.2B, or $47.50 per share
Subscribe for More Information
08:34 EDTAHLEndurance Specialty proposes to acquire Aspen Insurance for $47.50 per share

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use